Susquehanna International Group, LLP X4 Pharmaceuticals, Inc Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 172,813 shares of XFOR stock, worth $91,590. This represents 0.0% of its overall portfolio holdings.

Number of Shares

172,813

Previous 108,734 58.93%

Holding current value

$91,590

Previous $63,000 82.54%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.54 - $0.86 $34,602 - $55,107	64,079 Added 58.93%	172,813 $115,000
Q2 2024 Aug 15, 2024	SELL	$0.58 - $1.47 $228,479 - $579,078	-393,931 Reduced 78.37%	108,734 $63,000
Q1 2024 May 07, 2024	BUY	$0.72 - $1.46 $71,815 - $145,626	99,744 Added 24.76%	502,665 $698,000
Q4 2023 Feb 14, 2024	BUY	$0.61 - $0.99 $181,605 - $294,736	297,714 Added 282.98%	402,921 $338,000
Q3 2023 Nov 14, 2023	SELL	$1.03 - $2.02 $140,316 - $275,184	-136,230 Reduced 56.42%	105,207 $114,000
Q2 2023 Aug 11, 2023	SELL	$0.82 - $2.49 $33,710 - $102,363	-41,110 Reduced 14.55%	241,437 $468,000
Q1 2023 May 16, 2023	BUY	$0.8 - $1.22 $226,037 - $344,707	282,547 New	282,547 $245,000
Q3 2022 Nov 14, 2022	BUY	$0.89 - $1.71 $134,031 - $257,520	150,597 New	150,597 $258,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.91 $31,065 - $67,426	-35,302 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.48 - $2.58 $63,594 - $110,860	-42,969 Reduced 54.9%	35,302 $62,000
Q4 2021 Feb 14, 2022	SELL	$1.9 - $5.6 $113,544 - $334,656	-59,760 Reduced 43.29%	78,271 $179,000
Q3 2021 Nov 15, 2021	BUY	$4.53 - $6.45 $449,063 - $639,394	99,131 Added 254.84%	138,031 $730,000
Q2 2021 Aug 11, 2021	BUY	$6.49 - $9.56 $252,461 - $371,884	38,900 New	38,900 $253,000
Q4 2019 Feb 14, 2020	SELL	$9.93 - $14.33 $202,601 - $292,374	-20,403 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$11.06 - $15.75 $94,153 - $134,079	8,513 Added 71.6%	20,403 $259,000
Q2 2019 Aug 16, 2019	BUY	$12.57 - $21.67 $5,983 - $10,314	476 Added 4.17%	11,890 $178,000
Q2 2019 Aug 14, 2019	BUY	$12.57 - $21.67 $143,473 - $247,341	11,414 New	11,414 $171,000

Others Institutions Holding XFOR

# of Institutions

105

Shares Held

101M

Call Options Held

213K

Put Options Held

50.6K

View Full List

About X4 Pharmaceuticals, Inc

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $36.4M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

More about XFOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP X4 Pharmaceuticals, Inc Transaction History